Skip to main content
Top
Published in: Acta Neuropathologica 5/2010

01-05-2010 | Original Paper

Analysis of microdissected human neurons by a sensitive ELISA reveals a correlation between elevated intracellular concentrations of Aβ42 and Alzheimer’s disease neuropathology

Authors: Masakazu Hashimoto, Nenad Bogdanovic, Inga Volkmann, Mikio Aoki, Bengt Winblad, Lars O. Tjernberg

Published in: Acta Neuropathologica | Issue 5/2010

Login to get access

Abstract

In Alzheimer’s disease (AD), Purkinje neurons in the cerebellum are spared, while, for instance, pyramidal neurons in the hippocampus are neuropathologically affected. Several lines of evidence suggest that the pathogenesis could be induced by the concentration-dependent polymerization of the amyloid β-peptide (Aβ) into extracellular oligomers. The role of intracellular Aβ is not fully investigated, but recent data indicate that also this pool could be of importance. Here, we use laser capture microdissection microscopy for isolation of Purkinje neurons from AD cases and controls, and quantify the low levels of intracellular Aβ using a novel and highly sensitive ELISA. Similar to Cornu Ammonis 1 pyramidal neurons, the intracellular levels of the most toxic variant, Aβ42, as well as the Aβ42/Aβ40 ratio, were increased in Purkinje neurons from sporadic AD cases as compared to controls. However, the levels of Aβ42 as well as Aβ40 were clearly lower in Purkinje neurons than in pyramidal neurons. Based on the volume of the captured Purkinje neurons, the intraneuronal concentrations of Aβ42 were calculated to be 200 nM in sporadic AD cases and 90 nM in controls. The corresponding concentrations in pyramidal neurons from hippocampus were 3 μM and 660 nM, respectively. The Aβ40 concentration was not significantly altered in AD cases compared to controls. However, we found ten times higher concentration of Aβ40 in pyramidal neurons (10 μM) compared to Purkinje neurons (1 μM). Finally, we suggest that high concentration of intracellular Aβ42 correlates with vulnerability to AD neuropathology.
Literature
1.
go back to reference Amundson DM, Zhou M (1999) Fluorometric method for the enzymatic determination of cholesterol. J Biochem Biophys Methods 38:43–52CrossRefPubMed Amundson DM, Zhou M (1999) Fluorometric method for the enzymatic determination of cholesterol. J Biochem Biophys Methods 38:43–52CrossRefPubMed
2.
go back to reference Aoki M, Volkmann I, Tjernberg LO, Winblad B, Bogdanovic N (2008) Amyloid β-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer’s brain. Neuroreport 19:1085–1089CrossRefPubMed Aoki M, Volkmann I, Tjernberg LO, Winblad B, Bogdanovic N (2008) Amyloid β-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer’s brain. Neuroreport 19:1085–1089CrossRefPubMed
3.
go back to reference Batchelor RH, Zhou M (2002) A resorufin-based fluorescent assay for quantifying NADH. Anal Biochem 305:118–119CrossRefPubMed Batchelor RH, Zhou M (2002) A resorufin-based fluorescent assay for quantifying NADH. Anal Biochem 305:118–119CrossRefPubMed
4.
go back to reference Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) Intraneuronal Aβ causes the onset of early Alzheimer’s disease-related cognitive deficits in transgenic mice. Neuron 45:675–688CrossRefPubMed Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) Intraneuronal Aβ causes the onset of early Alzheimer’s disease-related cognitive deficits in transgenic mice. Neuron 45:675–688CrossRefPubMed
5.
go back to reference Bogdanovic N, Morris J (1995) Diagnostic criteria for Alzheimer’s disease in multicentre brain banking. In: Cruz-Sanchez FF, Ravid R, Cuzner ML (eds) Neuropathological diagnostic criteria for brain banking. IOS Press, Amsterdam, pp. 20–29 Bogdanovic N, Morris J (1995) Diagnostic criteria for Alzheimer’s disease in multicentre brain banking. In: Cruz-Sanchez FF, Ravid R, Cuzner ML (eds) Neuropathological diagnostic criteria for brain banking. IOS Press, Amsterdam, pp. 20–29
6.
go back to reference Borchelt DR, Thinakaran G, Eckman CB et al (1996) Familial Alzheimer’s disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17:1005–1013CrossRefPubMed Borchelt DR, Thinakaran G, Eckman CB et al (1996) Familial Alzheimer’s disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17:1005–1013CrossRefPubMed
7.
go back to reference Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259CrossRefPubMed Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259CrossRefPubMed
8.
go back to reference Caccamo A, Oddo S, Sugarman MC, Akbari Y, LaFerla FM (2005) Age- and region-dependent alterations in Aβ-degrading enzymes: implications for Aβ-induced disorders. Neurobiol Aging 26:645–654CrossRefPubMed Caccamo A, Oddo S, Sugarman MC, Akbari Y, LaFerla FM (2005) Age- and region-dependent alterations in Aβ-degrading enzymes: implications for Aβ-induced disorders. Neurobiol Aging 26:645–654CrossRefPubMed
9.
go back to reference Christensen DZ, Kraus SL, Flohr A, Cotel MC, Wirths O, Bayer TA (2008) Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice. Acta Neuropathol 116:647–655CrossRefPubMed Christensen DZ, Kraus SL, Flohr A, Cotel MC, Wirths O, Bayer TA (2008) Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice. Acta Neuropathol 116:647–655CrossRefPubMed
10.
go back to reference D’Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DH (2001) Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer’s disease. Histopathology 38:120–134CrossRefPubMed D’Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DH (2001) Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer’s disease. Histopathology 38:120–134CrossRefPubMed
11.
go back to reference Du J, Sun B, Chen K et al (2009) Metabolites of cerebellar neurons and hippocampal neurons play opposite roles in pathogenesis of Alzheimer’s disease. PLoS One 4:e5530CrossRefPubMed Du J, Sun B, Chen K et al (2009) Metabolites of cerebellar neurons and hippocampal neurons play opposite roles in pathogenesis of Alzheimer’s disease. PLoS One 4:e5530CrossRefPubMed
12.
go back to reference Echeverria V, Cuello AC (2002) Intracellular A-beta amyloid, a sign for worse things to come? Mol Neurobiol 26:299–316CrossRefPubMed Echeverria V, Cuello AC (2002) Intracellular A-beta amyloid, a sign for worse things to come? Mol Neurobiol 26:299–316CrossRefPubMed
13.
go back to reference Eckman EA, Eckman CB (2005) Aβ-degrading enzymes: modulators of Alzheimer’s disease pathogenesis and targets for therapeutic intervention. Biochem Soc Trans 33:1101–1105CrossRefPubMed Eckman EA, Eckman CB (2005) Aβ-degrading enzymes: modulators of Alzheimer’s disease pathogenesis and targets for therapeutic intervention. Biochem Soc Trans 33:1101–1105CrossRefPubMed
14.
go back to reference Gotz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301 l tau transgenic mice induced by Aβ 42 fibrils. Science 293:1491–1495CrossRefPubMed Gotz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301 l tau transgenic mice induced by Aβ 42 fibrils. Science 293:1491–1495CrossRefPubMed
15.
go back to reference Gouras GK, Tsai J, Näslund J et al (2000) Intraneuronal Aβ42 accumulation in human brain. Am J Pathol 156:15–20PubMed Gouras GK, Tsai J, Näslund J et al (2000) Intraneuronal Aβ42 accumulation in human brain. Am J Pathol 156:15–20PubMed
16.
go back to reference Gravina SA, Ho L, Eckman CB et al (1995) Amyloid β protein (Aβ) in Alzheimer’s disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43). J Biol Chem 270:7013–7016CrossRefPubMed Gravina SA, Ho L, Eckman CB et al (1995) Amyloid β protein (Aβ) in Alzheimer’s disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43). J Biol Chem 270:7013–7016CrossRefPubMed
17.
go back to reference Ha C, Park CB (2006) Ex situ atomic force microscopy analysis of β-amyloid self-assembly and deposition on a synthetic template. Langmuir 22:6977–6985CrossRefPubMed Ha C, Park CB (2006) Ex situ atomic force microscopy analysis of β-amyloid self-assembly and deposition on a synthetic template. Langmuir 22:6977–6985CrossRefPubMed
18.
go back to reference Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356CrossRefPubMed Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356CrossRefPubMed
19.
go back to reference Hashimoto M, Rockenstein E, Crews L, Masliah E (2003) Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer’s and Parkinson’s diseases. Neuromolecular Med 4:21–36CrossRefPubMed Hashimoto M, Rockenstein E, Crews L, Masliah E (2003) Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer’s and Parkinson’s diseases. Neuromolecular Med 4:21–36CrossRefPubMed
20.
go back to reference Jarrett JT, Berger EP, Lansbury PT Jr (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer’s disease. Biochemistry 32:4693–4697CrossRefPubMed Jarrett JT, Berger EP, Lansbury PT Jr (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer’s disease. Biochemistry 32:4693–4697CrossRefPubMed
21.
go back to reference Jin LW, Shie FS, Maezawa I, Vincent I, Bird T (2004) Intracellular accumulation of amyloidogenic fragments of amyloid-β precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. Am J Pathol 164:975–985PubMed Jin LW, Shie FS, Maezawa I, Vincent I, Bird T (2004) Intracellular accumulation of amyloidogenic fragments of amyloid-β precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. Am J Pathol 164:975–985PubMed
22.
go back to reference Joachim CL, Morris JH, Selkoe DJ (1989) Diffuse senile plaques occur commonly in the cerebellum in Alzheimer’s disease. Am J Pathol 135:309–319PubMed Joachim CL, Morris JH, Selkoe DJ (1989) Diffuse senile plaques occur commonly in the cerebellum in Alzheimer’s disease. Am J Pathol 135:309–319PubMed
23.
go back to reference Klein WL, Krafft GA, Finch CE (2001) Targeting small Aβ oligomers: the solution to an Alzheimer’s disease conundrum? Trends Neurosci 24:219–224CrossRefPubMed Klein WL, Krafft GA, Finch CE (2001) Targeting small Aβ oligomers: the solution to an Alzheimer’s disease conundrum? Trends Neurosci 24:219–224CrossRefPubMed
24.
go back to reference Lambert MP, Barlow AK, Chromy BA et al (1998) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448–6453CrossRefPubMed Lambert MP, Barlow AK, Chromy BA et al (1998) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448–6453CrossRefPubMed
25.
go back to reference Lewis J, Dickson DW, Lin WL et al (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487–1491CrossRefPubMed Lewis J, Dickson DW, Lin WL et al (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487–1491CrossRefPubMed
26.
go back to reference Mirra SS, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMed Mirra SS, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMed
27.
go back to reference Mori C, Spooner ET, Wisniewsk KE et al (2002) Intraneuronal Aβ42 accumulation in Down syndrome brain. Amyloid 9:88–102PubMed Mori C, Spooner ET, Wisniewsk KE et al (2002) Intraneuronal Aβ42 accumulation in Down syndrome brain. Amyloid 9:88–102PubMed
28.
go back to reference Näslund J, Haroutunian V, Mohs R et al (2000) Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. JAMA 283:1571–1577CrossRefPubMed Näslund J, Haroutunian V, Mohs R et al (2000) Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. JAMA 283:1571–1577CrossRefPubMed
29.
go back to reference Nordstedt C, Näslund J, Tjernberg LO, Karlstrom AR, Thyberg J, Terenius L (1994) The Alzheimer Aβ peptide develops protease resistance in association with its polymerization into fibrils. J Biol Chem 269:30773–30776PubMed Nordstedt C, Näslund J, Tjernberg LO, Karlstrom AR, Thyberg J, Terenius L (1994) The Alzheimer Aβ peptide develops protease resistance in association with its polymerization into fibrils. J Biol Chem 269:30773–30776PubMed
32.
go back to reference Selkoe DJ (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192:106–113CrossRefPubMed Selkoe DJ (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192:106–113CrossRefPubMed
33.
go back to reference Sengupta P, Garai K, Sahoo B, Shi Y, Callaway DJ, Maiti S (2003) The amyloid β peptide (Aβ1-40) is thermodynamically soluble at physiological concentrations. Biochemistry 42:10506–10513CrossRefPubMed Sengupta P, Garai K, Sahoo B, Shi Y, Callaway DJ, Maiti S (2003) The amyloid β peptide (Aβ1-40) is thermodynamically soluble at physiological concentrations. Biochemistry 42:10506–10513CrossRefPubMed
34.
go back to reference Shankar GM, Li S, Mehta TH et al (2008) Amyloid-β protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 14:837–842CrossRefPubMed Shankar GM, Li S, Mehta TH et al (2008) Amyloid-β protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 14:837–842CrossRefPubMed
35.
go back to reference Thal DR, Griffin WS, Braak H (2008) Parenchymal and vascular Aβ-deposition and its effects on the degeneration of neurons and cognition in Alzheimer’s disease. J Cell Mol Med 12:1848–1862PubMed Thal DR, Griffin WS, Braak H (2008) Parenchymal and vascular Aβ-deposition and its effects on the degeneration of neurons and cognition in Alzheimer’s disease. J Cell Mol Med 12:1848–1862PubMed
36.
go back to reference Thal DR, Rub U, Orantes M, Braak H (2002) Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800PubMed Thal DR, Rub U, Orantes M, Braak H (2002) Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800PubMed
37.
go back to reference Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J (2004) The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology 62:1984–1989PubMed Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J (2004) The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology 62:1984–1989PubMed
38.
go back to reference Verdile G, Gnjec A, Miklossy J et al (2004) Protein markers for Alzheimer disease in the frontal cortex and cerebellum. Neurology 63:1385–1392PubMed Verdile G, Gnjec A, Miklossy J et al (2004) Protein markers for Alzheimer disease in the frontal cortex and cerebellum. Neurology 63:1385–1392PubMed
39.
go back to reference Wang HY, D’Andrea MR, Nagele RG (2002) Cerebellar diffuse amyloid plaques are derived from dendritic Aβ42 accumulations in Purkinje cells. Neurobiol Aging 23:213–223CrossRefPubMed Wang HY, D’Andrea MR, Nagele RG (2002) Cerebellar diffuse amyloid plaques are derived from dendritic Aβ42 accumulations in Purkinje cells. Neurobiol Aging 23:213–223CrossRefPubMed
40.
go back to reference Welander H, Frånberg J, Graff C, Sundstrom E, Winblad B, Tjernberg LO (2009) Aβ43 is more frequent than Aβ40 in amyloid plaque cores from Alzheimer disease brains. J Neurochem 110:697–706CrossRefPubMed Welander H, Frånberg J, Graff C, Sundstrom E, Winblad B, Tjernberg LO (2009) Aβ43 is more frequent than Aβ40 in amyloid plaque cores from Alzheimer disease brains. J Neurochem 110:697–706CrossRefPubMed
41.
go back to reference Wenk GL (2003) Neuropathologic changes in Alzheimer’s disease. J Clin Psychiatry 64(Suppl 9):7–10PubMed Wenk GL (2003) Neuropathologic changes in Alzheimer’s disease. J Clin Psychiatry 64(Suppl 9):7–10PubMed
42.
go back to reference Wirths O, Breyhan H, Cynis H, Schilling S, Demuth HU, Bayer TA (2009) Intraneuronal pyroglutamate-Abeta 3–42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model. Acta Neuropathol 118:487–496CrossRefPubMed Wirths O, Breyhan H, Cynis H, Schilling S, Demuth HU, Bayer TA (2009) Intraneuronal pyroglutamate-Abeta 3–42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model. Acta Neuropathol 118:487–496CrossRefPubMed
43.
go back to reference Wirths O, Multhaup G, Czech C et al (2001) Intraneuronal Aβ accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci Lett 306:116–120CrossRefPubMed Wirths O, Multhaup G, Czech C et al (2001) Intraneuronal Aβ accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci Lett 306:116–120CrossRefPubMed
44.
go back to reference Wood SJ, Maleeff B, Hart T, Wetzel R (1996) Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer’s amyloid peptide Aβ. J Mol Biol 256:870–877CrossRefPubMed Wood SJ, Maleeff B, Hart T, Wetzel R (1996) Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer’s amyloid peptide Aβ. J Mol Biol 256:870–877CrossRefPubMed
45.
go back to reference Yasojima K, Akiyama H, McGeer EG, McGeer PL (2001) Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide. Neurosci Lett 297:97–100CrossRefPubMed Yasojima K, Akiyama H, McGeer EG, McGeer PL (2001) Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide. Neurosci Lett 297:97–100CrossRefPubMed
46.
go back to reference Zhou M, Diwu Z, Panchuk-Voloshina N, Haugland RP (1997) A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal Biochem 253:162–168CrossRefPubMed Zhou M, Diwu Z, Panchuk-Voloshina N, Haugland RP (1997) A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal Biochem 253:162–168CrossRefPubMed
Metadata
Title
Analysis of microdissected human neurons by a sensitive ELISA reveals a correlation between elevated intracellular concentrations of Aβ42 and Alzheimer’s disease neuropathology
Authors
Masakazu Hashimoto
Nenad Bogdanovic
Inga Volkmann
Mikio Aoki
Bengt Winblad
Lars O. Tjernberg
Publication date
01-05-2010
Publisher
Springer-Verlag
Published in
Acta Neuropathologica / Issue 5/2010
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-010-0661-6

Other articles of this Issue 5/2010

Acta Neuropathologica 5/2010 Go to the issue